�7%) is recommended among diabetics to reduce microvascular complications and, with
lesser certainty, macrovascular complications. Patients with
elevated cholesterol, comorbid coronary artery disease, or
evidence of an atherosclerotic origin should be managed
according to NCEP III guidelines, which include lifestyle
modification and/or medications. Statin agents are recommended targeting low density lipoprotein cholesterol
(LDL-C) of ⬍100 mg/d